SC 13G

Company

Carisma Therapeutics Inc.

Filed

May 25, 2016

Accession Number

0001193125-16-602420

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →